Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA9 | Q16790 | 7/20 | 0.47 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL594676 | 0.98 | TDP1 (0.56) | TDP1MEN1GAAKMT2AEPHX1 | |
| Ammonia Solution, Strong SCHEMBL17160804 | 0.98 | TDP1 (0.56) | TDP1MEN1GAAKMT2AEPHX1 | |
| SCHEMBL3341020 | 0.91 | TDP1 (0.67) | TDP1MEN1GAAKMT2AEPHX1 | |
| SCHEMBL23568999 | 0.89 | TDP1 (0.49) | TDP1MEN1GAAKMT2AEPHX1 | |
| SCHEMBL691053 | 0.88 | TDP1 (0.70) | TDP1MEN1GAAKMT2AEPHX1 | |
| SCHEMBL694362 | 0.88 | TDP1 (0.65) | TDP1MEN1GAAKMT2AEPHX1 | |
| SCHEMBL10243062 | 0.87 | TDP1 (0.46) | TDP1MEN1GAAKMT2AEPHX1 | |
| Bromide SCHEMBL17818451 | 0.86 | TDP1 (0.62) | TDP1MEN1GAAKMT2AEPHX1 | |
| SCHEMBL21996829 | 0.86 | TDP1 (0.73) | TDP1MEN1GAAKMT2AEPHX1 | |
| SCHEMBL12772839 | 0.86 | TDP1 (0.73) | TDP1MEN1GAAKMT2AEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 911 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307597-A | Mitochondrial-targeted hypoxia response prodrug as well as preparation method and application thereof | 中山大学 | 2024-07-09 | — | — | CN | claimed |
| CN-117384642-A | Selective etching solution | 湖北兴福电子材料股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-114437094-A | Alkaloid with antitumor activity, and preparation method and application thereof | 西藏大学 | 2022-05-06 | — | — | CN | claimed |
| CN-109879780-B | Preparation method of (2-methylamine-ethyl) -tert-butyl carbamate | 上海卡洛化学有限公司 | 2021-06-29 | — | — | CN | claimed |
| WO-2016029146-A1 | SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE | UNIVERSITY OF WASHINGTON (US) | 2016-02-25 | — | — | WO | claimed |
| US-20260146042-A1 | PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2026-05-28 | — | — | US | disclosed |
| EP-3761989-B1 | IMIDAZODIAZEPINEDIONES AND METHODS OF USE THEREOF | GFB ABC LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12617797-B2 | Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain | ESTEVE PHARMACEUTICALS, S.A. (ES) | 2026-05-05 | — | — | US | disclosed |
| US-12617805-B2 | Codrug that disintegrates in intestine, preparation therefor, and use thereof | ENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD. (CN) | 2026-05-05 | — | — | US | disclosed |
| WO-2026087635-A1 | DIHYDRO BENZOXAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4731611-A1 | TARGETED DEGRADERS OF HIV-1 NEF FOR THE TREATMENT OF HIV DISEASE | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12612427-B2 | Aryl glucoside derivative, preparation method therefor and application thereof | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2026-04-28 | — | — | US | disclosed |
| US-6410576-B1 | ANTIINFLAMMATORY AGENTS; CARDIOVASCULAR DISORDERS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2002-06-25 | — | — | US | disclosed |
| EP-1212299-A1 | SUBSTITUTED PIPERIDINE COMPOUNDS USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | AstraZeneca UK Limited (GB) | 2002-06-12 | — | — | EP | disclosed |
| EP-0874841-B1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR ANTAGONISTS | FOURNIER IND & SANTE (FR) | 2001-10-04 | — | — | EP | disclosed |
| EP-1103560-A1 | NOVEL THIAZOLIDINE DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2001-05-30 | — | — | EP | disclosed |
| US-6211181-B1 | ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIALLERGENS, AND ANTIASTHMATICS | FOURNIER INDUSTRIE ET SANTE (FR) | 2001-04-03 | — | — | US | disclosed |
| WO-2001014333-A1 | SUBSTITUTED PIPERIDINE COMPOUNDS USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | ASTRAZENECA UK LIMITED (GB) | 2001-03-01 | — | — | WO | disclosed |
| EP-0874841-A1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR B2 ANTAGONISTS | FOURNIER INDUSTRIE ET SANTE (FR) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997024349-A1 | 1-BENZENESULFONYL PYRROLIDINE DERIVATIVES AS BRADYKININ RECEPTOR ANTAGONISTS | FOURNIER INDUSTRIE ET SANTE (FR) | 1997-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146042-A1 | PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES | CDK9, CDK6, CDK7 | TDP1 326/4885MEN1 2512/4885GAA 3092/4885 |
| US-12617797-B2 | Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain | SIGMAR1, OPRD1, OPRL1 | TDP1 2306/4885MEN1 4846/4885GAA 4476/4885 |
| US-12612427-B2 | Aryl glucoside derivative, preparation method therefor and application thereof | SLC5A1, SLC10A1, SLC5A2 | TDP1 2174/4885MEN1 1849/4885GAA 968/4885 |
| US-12617805-B2 | Codrug that disintegrates in intestine, preparation therefor, and use thereof | IRAK4, JAK1, VIP | TDP1 1482/4885MEN1 2797/4885GAA 4805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.